EU has agreed supply of 20,000 additional doses of Remdesivir
Oct 07, 2020 05:14 PM IST
A spokesman for the EU executive said Brussels had agreed with Gilead last Friday the supply of nearly 20,300 additional doses for the treatment of about 3,400 patients.
The European Commission said on Wednesday it had agreed with U.S. company Gilead the supply of more than 20,000 additional doses of its Covid-19 drug Remdesivir, in a bid to tackle shortages of the medication in European countries.
A spokesman for the EU executive said Brussels had agreed with Gilead last Friday the supply of nearly 20,300 additional doses for the treatment of about 3,400 patients.
Hindustan Times - your fastest source for breaking news! Read now.
It said it had paid 7 million euros ($8.2 million) for the new supply, which is in addition to 30,000 courses of treatment it had bought at the end of July.
Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now! Get Latest World News along with Latest News from India at Hindustan Times.
Share this article